Skip to main content
Top
Published in: Current Oncology Reports 5/2020

01-05-2020 | Glioma | Correction

Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma

Authors: Kyle Wierzbicki, Karthik Ravi, Andrea Franson, Amy Bruzek, Evan Cantor, Micah Harris, Morgan J. Homan, Bernard L. Marini, Abed Rahman Kawakibi, Ramya Ravindran, Rodrigo Teodoro, Viveka Nand Yadav, Carl Koschmann

Published in: Current Oncology Reports | Issue 5/2020

Login to get access

Excerpt

Correction to: Current Oncology Reports (2020) 22:19.
Metadata
Title
Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma
Authors
Kyle Wierzbicki
Karthik Ravi
Andrea Franson
Amy Bruzek
Evan Cantor
Micah Harris
Morgan J. Homan
Bernard L. Marini
Abed Rahman Kawakibi
Ramya Ravindran
Rodrigo Teodoro
Viveka Nand Yadav
Carl Koschmann
Publication date
01-05-2020
Publisher
Springer US
Published in
Current Oncology Reports / Issue 5/2020
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-020-00912-z

Other articles of this Issue 5/2020

Current Oncology Reports 5/2020 Go to the issue

Interventional Oncology (DC Madoff, Section Editor)

Percutaneous Management of Cancer Pain

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine